CG

Carol Gallagher

Independent Board Director

Del Mar, California

Overview

Work Experience

SE

Self Employed

  • Independent Board Director

    2024 - Current

NE

New Enterprise Associates (NEA)

  • Venture Advisor

    2023 - 2024

  • Venture Partner

    2019 - 2023

  • Partner

    2014 - 2023

CP

Calistoga Pharmaceuticals

  • Past President and CEO

    2008 - 2011

Metastatix, Inc.

  • President and CEO

    2007 - 2008

AP

Anadys Pharmaceuticals

  • SVP, Corporate Development

    2006 - 2007

Anadys Pharmaceutcials

  • SVP, Corp Development

    2006 - 2007

CancerVax

  • VP, Sales, Markeitng, and Product Planning

    2004 - 2006

BI

Biogen Idec

  • Director, Oncology Marketing and Rituxan Team Leader

    2002 - 2004

IP

Idec Pharmaceuticals

  • Senior Director, Oncology Marketing

    2002 - 2003

P

Pfizer

  • Director, New Product Planning

    2000 - 2001

Education

Investments

Recludix Pharma

Series A

Total Funding: $60M

Millendo Therapeutics

Series B

Total Funding: $110M

Metacrine

Series B

Total Funding: $140M

Pionyr Immunotherapeutics

Series B

Total Funding: $79M

Relevant Websites